Parkinsonism and Seizures in Fahr’s Disease: A Report of Two Cases

Fahr’s disease, also known as primary familial calcifications, is a rare neurodegenerative disorder characterised by abnormal calcium deposits in the brain caused by genetic mutations. Fahr’s syndrome, or secondary brain calcification, results from infections, metabolic, and endocrine abnormalities...

Full description

Saved in:
Bibliographic Details
Main Authors: Bolisetty Shanmukha Sai, Tankasala Gangaram, Taruguvandla Sandhya Rani, Jennie Santhanam, SN Meenakshi Sundari
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2025-08-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2025&month=August&volume=19&issue=8&page=OD20-OD23&id=21377
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849394182283591680
author Bolisetty Shanmukha Sai
Tankasala Gangaram
Taruguvandla Sandhya Rani
Jennie Santhanam
SN Meenakshi Sundari
author_facet Bolisetty Shanmukha Sai
Tankasala Gangaram
Taruguvandla Sandhya Rani
Jennie Santhanam
SN Meenakshi Sundari
author_sort Bolisetty Shanmukha Sai
collection DOAJ
description Fahr’s disease, also known as primary familial calcifications, is a rare neurodegenerative disorder characterised by abnormal calcium deposits in the brain caused by genetic mutations. Fahr’s syndrome, or secondary brain calcification, results from infections, metabolic, and endocrine abnormalities leading to calcium deposits in the brain. Although Fahr’s disease and Fahr’s syndrome are recognised as separate entities, they are often used interchangeably in the literature. The prevalence of Fahr’s disease is <1 per 100,000, with no significant gender differences, and it often goes undiagnosed since one-third of the patients are asymptomatic. Patients may present with headaches, movement disorders, seizures, cognitive defects, and psychiatric manifestations, which are usually mistaken for other neurological conditions. The pathophysiology is still unclear but is postulated to be due to abnormal calcium and phosphate metabolism and transport in the brain. Fahr’s disease can be diagnosed based solely on neuroimaging, even without an identifiable etiology. While genetic testing is supportive, it is not mandatory, as many patients lack mutations despite a positive family history. Both conditions show characteristic symmetrical calcifications in the basal ganglia, as well as areas like the thalamus, cerebellum, and subcortical white matter on neuroimaging. Management primarily focuses on symptomatic treatment to control movement disorders, preserve cognition, and alleviate neuropsychiatric manifestations through a multidisciplinary approach. Through this case report, the authors highlight two cases with brain calcifications and their management. The first patient had parkinsonian features, while the second patient experienced a generalized tonic-clonic seizure and were diagnosed with Fahr’s disease due to an unidentifiable etiology and Fahr’s syndrome due to hypoparathyroidism, respectively.
format Article
id doaj-art-6ae9ad2937be4f6da299db9ec0cbb66e
institution Kabale University
issn 2249-782X
0973-709X
language English
publishDate 2025-08-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj-art-6ae9ad2937be4f6da299db9ec0cbb66e2025-08-20T03:40:07ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2025-08-01198OD20OD2310.7860/JCDR/2025/80428.21377Parkinsonism and Seizures in Fahr’s Disease: A Report of Two CasesBolisetty Shanmukha Sai0Tankasala Gangaram1Taruguvandla Sandhya Rani2Jennie Santhanam3SN Meenakshi Sundari4Postgraduate Student, Department of General Medicine, SRM Medical College, Hospital and Research Centre, Chennai, Tamil Nadu, India.Postgraduate Student, Department of General Medicine, SRM Medical College, Hospital and Research Centre, Chennai, Tamil Nadu, India.Postgraduate Student, Department of General Medicine, SRM Medical College, Hospital and Research Centre, Chennai, Tamil Nadu, India.Professor, Department of General Medicine, SRM Medical College, Hospital and Research Centre, Chennai, Tamil Nadu, India.Professor, Department of General Medicine, SRM Medical College, Hospital and Research Centre, Chennai, Tamil Nadu, India.Fahr’s disease, also known as primary familial calcifications, is a rare neurodegenerative disorder characterised by abnormal calcium deposits in the brain caused by genetic mutations. Fahr’s syndrome, or secondary brain calcification, results from infections, metabolic, and endocrine abnormalities leading to calcium deposits in the brain. Although Fahr’s disease and Fahr’s syndrome are recognised as separate entities, they are often used interchangeably in the literature. The prevalence of Fahr’s disease is <1 per 100,000, with no significant gender differences, and it often goes undiagnosed since one-third of the patients are asymptomatic. Patients may present with headaches, movement disorders, seizures, cognitive defects, and psychiatric manifestations, which are usually mistaken for other neurological conditions. The pathophysiology is still unclear but is postulated to be due to abnormal calcium and phosphate metabolism and transport in the brain. Fahr’s disease can be diagnosed based solely on neuroimaging, even without an identifiable etiology. While genetic testing is supportive, it is not mandatory, as many patients lack mutations despite a positive family history. Both conditions show characteristic symmetrical calcifications in the basal ganglia, as well as areas like the thalamus, cerebellum, and subcortical white matter on neuroimaging. Management primarily focuses on symptomatic treatment to control movement disorders, preserve cognition, and alleviate neuropsychiatric manifestations through a multidisciplinary approach. Through this case report, the authors highlight two cases with brain calcifications and their management. The first patient had parkinsonian features, while the second patient experienced a generalized tonic-clonic seizure and were diagnosed with Fahr’s disease due to an unidentifiable etiology and Fahr’s syndrome due to hypoparathyroidism, respectively.https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2025&month=August&volume=19&issue=8&page=OD20-OD23&id=21377basal ganglia diseasesbrain calcificationshypoparathyroidismneurodegenerative disease
spellingShingle Bolisetty Shanmukha Sai
Tankasala Gangaram
Taruguvandla Sandhya Rani
Jennie Santhanam
SN Meenakshi Sundari
Parkinsonism and Seizures in Fahr’s Disease: A Report of Two Cases
Journal of Clinical and Diagnostic Research
basal ganglia diseases
brain calcifications
hypoparathyroidism
neurodegenerative disease
title Parkinsonism and Seizures in Fahr’s Disease: A Report of Two Cases
title_full Parkinsonism and Seizures in Fahr’s Disease: A Report of Two Cases
title_fullStr Parkinsonism and Seizures in Fahr’s Disease: A Report of Two Cases
title_full_unstemmed Parkinsonism and Seizures in Fahr’s Disease: A Report of Two Cases
title_short Parkinsonism and Seizures in Fahr’s Disease: A Report of Two Cases
title_sort parkinsonism and seizures in fahr s disease a report of two cases
topic basal ganglia diseases
brain calcifications
hypoparathyroidism
neurodegenerative disease
url https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2025&month=August&volume=19&issue=8&page=OD20-OD23&id=21377
work_keys_str_mv AT bolisettyshanmukhasai parkinsonismandseizuresinfahrsdiseaseareportoftwocases
AT tankasalagangaram parkinsonismandseizuresinfahrsdiseaseareportoftwocases
AT taruguvandlasandhyarani parkinsonismandseizuresinfahrsdiseaseareportoftwocases
AT jenniesanthanam parkinsonismandseizuresinfahrsdiseaseareportoftwocases
AT snmeenakshisundari parkinsonismandseizuresinfahrsdiseaseareportoftwocases